Characterization of unusual hexosaminidase A (HEX A) deficient human mutants
- PMID: 747188
- PMCID: PMC1685872
Characterization of unusual hexosaminidase A (HEX A) deficient human mutants
Abstract
Two families with unusual hexosaminidase A (HEX A) mutations are described. In one, the proband had the Tay-Sachs disease phenotype with considerable HEX A activity. In the second, the proband was phenotypically normal with absent HEX A activity. Activities using ganglioside GM2 as substrate demonstrate markedly reduced activities in the first case and half-normal activities in the second. Pedigree analyses indicate the presence of two different mutations. In the first, the proband appears to be an allelic compound HEX A 2-4 where mutation HEX A 4 leads to a diminution of HEX A activity against GM2 but not for the synthetic substrate, 4MU-beta-D-N-acetyl-glucosaminide, with HEX A 2 being the Tay-Sachs disease (or similar) mutation. In the second family, the proband is an allelic compound HEX A 2-5 where mutation HEX A 5 leads to a diminution of HEX A activity against the synthetic substrate, 4MU-beta-D-N-acetyl-glucosaminide, but not for GM2. The presence of either mutation will lead to false-negative (HEX A 4) or false-positive (HEX A 5) assignments of heterozygosity or homozygosity for GM2 gangliosidosis when synthetic substrates are employed. In both families, DM2 N-acetyl-beta-D-galactosaminidase activity in fibroblasts was an accurate determinant of phenotype.
Similar articles
-
Ganglioside GM2 N-acetyl-beta-D-galactosaminidase and asialo GM2 (GA2) N-acetyl-beta-D-galactosaminidase; studies in human skin fibroblasts.Clin Genet. 1977 Mar;11(3):171-83. doi: 10.1111/j.1399-0004.1977.tb01296.x. Clin Genet. 1977. PMID: 13950
-
GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.Am J Hum Genet. 1985 Nov;37(6):1071-82. Am J Hum Genet. 1985. PMID: 2934978 Free PMC article.
-
Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.Am J Hum Genet. 1983 Jul;35(4):551-64. Am J Hum Genet. 1983. PMID: 6224417 Free PMC article.
-
[Recent advances in molecular genetics of GM2 gangliosidosis].Nihon Rinsho. 1995 Dec;53(12):2988-93. Nihon Rinsho. 1995. PMID: 8577047 Review. Japanese.
-
Biochemical characterization of the GM2 gangliosidosis B1 variant.Braz J Med Biol Res. 2004 Jun;37(6):777-83. doi: 10.1590/s0100-879x2004000600001. Epub 2004 May 27. Braz J Med Biol Res. 2004. PMID: 15264019 Review.
Cited by
-
The GM2 gangliosidoses: Unlocking the mysteries of pathogenesis and treatment.Neurosci Lett. 2021 Nov 1;764:136195. doi: 10.1016/j.neulet.2021.136195. Epub 2021 Aug 25. Neurosci Lett. 2021. PMID: 34450229 Free PMC article. No abstract available.
-
"Pseudodeficiencies" of lysosomal hydrolases.Am J Hum Genet. 1994 Jun;54(6):934-40. Am J Hum Genet. 1994. PMID: 7911004 Free PMC article. Review. No abstract available.
-
A second mutation associated with apparent beta-hexosaminidase A pseudodeficiency: identification and frequency estimation.Am J Hum Genet. 1993 Dec;53(6):1198-205. Am J Hum Genet. 1993. PMID: 7902672 Free PMC article.
-
Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.Biochem J. 1980 Mar 1;185(3):583-91. doi: 10.1042/bj1850583. Biochem J. 1980. PMID: 7387624 Free PMC article.
-
Human neutral alpha-glucosidase C: genetic polymorphism including a "null" allele.Am J Hum Genet. 1980 Jul;32(4):497-507. Am J Hum Genet. 1980. PMID: 6994494 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources